Fatty acid modulation of the endocannabinoid system and the effect on food intake and metabolism

International Journal of Endocrinology

Volumn 2013, Issue , 2013, Pages

  Naughton, Shaan S ^a   Mathai, Michael L ^a,b   Hryciw, Deanne H ^b   McAinch, Andrew J ^a  

^a VICTORIA UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID 1 RECEPTOR; DOCOSAHEXAENOIC ACID; ENDOCANNABINOID; FATTY ACID; G PROTEIN COUPLED RECEPTOR; ICOSAPENTAENOIC ACID; MONOUNSATURATED FATTY ACID; OLEIC ACID; SATURATED FATTY ACID;

BODY MASS; CALORIC INTAKE; DIETARY INTAKE; DISEASE ASSOCIATION; FAT INTAKE; FATTY ACID ANALYSIS; FATTY ACID METABOLISM; FATTY ACID SYNTHESIS; FOOD INTAKE; HUMAN; LEAN BODY WEIGHT; LIPID DIET; NONHUMAN; OBESITY; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84879307688     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2013/361895     Document Type: Review

References (128)

1. Flegal K. M., Carroll M. D., Ogden C. L., Curtin L. R., Prevalence and trends in obesity among US adults, 1999-2008. Journal of the American Medical Association 2010 303 3 235 241 2-s2.0-74549140993 10.1001/jama.2009.2014
2. Withrow D., Alter D. A., The economic burden of obesity worldwide: a systematic review of the direct costs of obesity. Obesity Reviews 2011 12 2 131 141 2-s2.0-78851468865 10.1111/j.1467-789X.2009.00712.x
3. Hill J. O., Understanding and addressing the epidemic of obesity: an energy balance perspective. Endocrine Reviews 2006 27 7 750 761 2-s2.0-33845589453 10.1210/er.2006-0032
4. Erlanson-Albertsson C., How palatable food disrupts appetite regulation. Basic and Clinical Pharmacology and Toxicology 2005 97 2 61 73 2-s2.0-22544485065 10.1111/j.1742-7843.2005.pto-179.x
5. Popkin B. M., The nutrition transition and obesity in the developing world. The Journal of Nutrition 2001 131 3 871S 873S 2-s2.0-0035095990
6. Mela D. J., Eating for pleasure or just wanting to eat? Reconsidering sensory hedonic responses as a driver of obesity. Appetite 2006 47 1 10 17 2-s2.0-33745871197 10.1016/j.appet.2006.02.006
7. Devane W. A., Dysarz F. A., Johnson M. R., Melvin L. S., Howlett A. C., Determination and characterization of a cannabinoid receptor in rat brain. Molecular Pharmacology 1988 34 5 605 613 2-s2.0-0024263922
8. Howlett A. C., Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes. Molecular Pharmacology 1985 27 4 429 436 2-s2.0-0021966402
9. Monteleone P., Piscitelli F., Scognamiglio P., Monteleone A. M., Canestrelli B., Di Marzo V., Maj M., Hedonic eating is associated with increased peripheral levels of ghrelin and the endocannabinoid 2-arachidonoyl-glycerol in healthy humans: a pilot study. The Journal of Clinical Endocrinology and Metabolism 2012 97 6 E917 E924 10.1210/jc.2011-3018
10. Kirkham T. C., Williams C. M., Fezza F., Di Marzo V., Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. British Journal of Pharmacology 2002 136 4 550 557 2-s2.0-0035984946
11. Williams C. M., Kirkham T. C., Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. Psychopharmacology 1999 143 3 315 317 2-s2.0-0032936642 10.1007/s002130050953
12. Mechoulam R., Ben-Shabat S., Hanuš L., Ligumsky M., Kaminski N. E., Schatz A. R., Gopher A., Almog S., Martin B. R., Compton D. R., Pertwee R. G., Griffin G., Bayewitch M., Barg J., Vogel Z., Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochemical Pharmacology 1995 50 1 83 90 2-s2.0-0029012014 10.1016/0006-2952(95) 00109-D
13. Munro S., Thomas K. L., Abu-Shaar M., Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993 365 6441 61 65 2-s2.0-0027515373 10.1038/365061a0
14. Berrendero F., Sepe N., Ramos J. A., Di Marzo V., Fernández-Ruiz J. J., Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period. Synapse 1999 33 3 181 191 10.1002/(SICI)1098-2396(19990901)33:3<181::AID-SYN3>3.0.CO;2-R
15. Soria-Gómez E., Matias I., Rueda-Orozco P. E., Cisneros M., Petrosino S., Navarro L., Di Marzo V., Prospéro-García O., Pharmacological enhancement of the endocannabinoid system in the nucleus accumbens shell stimulates food intake and increases c-Fos expression in the hypothalamus. British Journal of Pharmacology 2007 151 7 1109 1116 2-s2.0-34547574943 10.1038/sj.bjp.0707313
16. Edwards D. A., Kim J., Alger B. E., Multiple mechanisms of endocannabinoid response initiation in hippocampus. Journal of Neurophysiology 2006 95 1 67 75 2-s2.0-33644813973 10.1152/jn.00813.2005
17. Miller C. C., Murray T. F., Freeman K. G., Edwards G. L., Cannabinoid agonist, CP 55,940, facilitates intake of palatable foods when injected into the hindbrain. Physiology and Behavior 2004 80 5 611 616 2-s2.0-1242337340 10.1016/j.physbeh.2003.10.019
18. Paquette J. J., Wang H. Y., Bakshi K., Olmstead M. C., Cannabinoid-induced tolerance is associated with a CB1 receptor G protein coupling switch that is prevented by ultra-low dose rimonabant. Behavioural Pharmacology 2007 18 8 767 776 2-s2.0-35948993422 10.1097/FBP.0b013e3282f15890
19. Devane W. A., Hanus L., Breuer A., Pertwee R. G., Stevenson L. A., Griffin G., Gibson D., Mandelbaum A., Etinger A., Mechoulam R., Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992 258 5090 1946 1949 2-s2.0-0027078685
20. Hillard C. J., Manna S., Greenberg M. J., Dicamelli R., Ross R. A., Stevenson L. A., Murphy V., Pertwee R. G., Campbell W. B., Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1). Journal of Pharmacology and Experimental Therapeutics 1999 289 3 1427 1433 2-s2.0-0033060910
21. Sugiura T., Kodaka T., Nakane S., Miyashita T., Kondo S., Suhara Y., Takayama H., Waku K., Seki C., Baba N., Ishima Y., Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor: structure-activity relationship of 2-arachidonoylglycerol, ether- linked analogues, and related compounds. Journal of Biological Chemistry 1999 274 5 2794 2801 2-s2.0-0033614020 10.1074/jbc.274.5.2794
22. Sugiura T., Kondo S., Kishimoto S., Miyashita T., Nakane S., Kodaka T., Suhara Y., Takayama H., Waku K., Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells. Journal of Biological Chemistry 2000 275 1 605 612 2-s2.0-0034614374 10.1074/jbc.275.1.605
23. Overton H. A., Babbs A. J., Doel S. M., Fyfe M. C. T., Gardner L. S., Griffin G., Jackson H. C., Procter M. J., Rasamison C. M., Tang-Christensen M., Widdowson P. S., Williams G. M., Reynet C., Deorphanization of a G protein-coupled receptor for oleoyl ethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell Metabolism 2006 3 3 167 175 2-s2.0-33644627958 10.1016/j.cmet.2006.02.004
24. Oh D. Y., Talukdar S., Bae E. J., Imamura T., Morinaga H., Fan W., Li P., Lu W. J., Watkins S. M., Olefsky J. M., GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010 142 5 687 698 2-s2.0-77956165390 10.1016/j.cell.2010.07.041
25. Berger A., Crozier G., Bisogno T., Cavaliere P., Innis S., Di Marzo V., Anandamide and diet: inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets. Proceedings of the National Academy of Sciences of the United States of America 2001 98 11 6402 6406 2-s2.0-0035932974 10.1073/pnas.101119098
26. Alvheim A. R., Malde M. K., Osei-Hyiaman D., Hong Lin Y., Pawlosky R., Madsen L., Kristiansen K., Frøyland L., Hibbeln J. R., Dietary linoleic acid elevates endogenous 2-AG and anandamide and induces obesity. Obesity (Silver Spring) 2012 20 10 1984 1994 10.1038/oby.2012.38
27. Petersen G., Sørensen C., Schmid P. C., Artmann A., Tang-Christensen M., Hansen S. H., Larsen P. J., Schmid H. H. O., Hansen H. S., Intestinal levels of anandamide and oleoyl ethanolamide in food-deprived rats are regulated through their precursors. Biochimica et Biophysica Acta-Molecular and Cell Biology of Lipids 2006 1761 2 143 150 2-s2.0-33646486532 10.1007/s00239-004-0305-3
28. Oddi S., Fezza F., Pasquariello N., De Simone C., Rapino C., Dainese E., Finazzi-Agrò A., Maccarrone M., Evidence for the intracellular accumulation of anandamide in adiposomes. Cellular and Molecular Life Sciences 2008 65 5 840 850 2-s2.0-40449103413 10.1007/s00018-008-7494-7
29. Blasbalg T. L., Hibbeln J. R., Ramsden C. E., Majchrzak S. F., Rawlings R. R., Changes in consumption of omega-3 and omega-6 fatty acids in the United States during the 20th century. American Journal of Clinical Nutrition 2011 93 5 950 962 2-s2.0-79955455705 10.3945/ajcn.110.006643
30. Harris W. S., Klurfeld D. M., Twentieth-century trends in essential fatty acid intakes and the predicted omega-3 index: evidence versus estimates. American Journal of Clinical Nutrition 2011 93 5 907 908 2-s2.0-79955376502 10.3945/ajcn.111.014365
31. Salem N., Pawlosky R., Wegher B., Hibbeln J., In vivo conversion of linoleic acid to arachidonic acid in human adults. Prostaglandins Leukotrienes and Essential Fatty Acids 1999 60 5-6 407 410 2-s2.0-0032772197 10.1016/S0952-3278(99)80021-0
32. Sugiura T., Biosynthesis of anandamide and 2-arachidonoylglycerol. Cannabinoids and the Brain 2008 15 30
33. Cravatt B. F., Demarest K., Patricelli M. P., Bracey M. H., Giang D. K., Martin B. R., Lichtman A. H., Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proceedings of the National Academy of Sciences of the United States of America 2001 98 16 9371 9376 2-s2.0-0035979244 10.1073/pnas.161191698
34. Cadas H., Di Tomaso E., Piomelli D., Occurrence and biosynthesis of endogenous cannabinoid precursor, N- arachidonoyl phosphatidylethanolamine, in rat brain. The Journal of Neuroscience 1997 17 4 1226 1242 2-s2.0-0031033841
35. Okamoto Y., Morishita J., Tsuboi K., Tonai T., Ueda N., Molecular characterization of a phospholipase D generating anandamide and its congeners. Journal of Biological Chemistry 2004 279 7 5298 5305 2-s2.0-1242294480 10.1074/jbc.M306642200
36. Venance L., Stella N., Glowinski J., Giaume C., Mechanism involved in initiation and propagation of receptor-induced intercellular calcium signaling in cultured rat astrocytes. The Journal of Neuroscience 1997 17 6 1981 1992 2-s2.0-0031030073
37. 2+-dependent and-independent mechanisms. The FEBS Letters 1998 429 2 152 156 2-s2.0-0032511165 10.1016/S0014-5793(98)00581-X
38. Tsutsumi T., Kobayashi T., Ueda H., Yamauchi E., Watanabe S., Okuyama H., Lysophosphoinositide-specific phospholipase C in rat brain synaptic plasma membranes. Neurochemical Research 1994 19 4 399 406 2-s2.0-0028049622
39. Turu G., Várnal P., Gyombolai P., Szidonya L., Offertaler L., Bagdy G., Kunos G., Hunyady L., Paracrine transactivation of the CB1 cannabinoid receptor by AT1 angiotensin and other Gq/11 protein-coupled receptors. Journal of Biological Chemistry 2009 284 25 16914 16921 2-s2.0-67650564947 10.1074/jbc.M109.003681
40. Turu G., Simon A., Gyombolai P., Szidonya L., Bagdy G., Lenkei Z., Hunyady L., The role of diacylglycerol lipase in constitutive and angiotensin AT 1 receptor-stimulated cannabinoid CB1 receptor activity. Journal of Biological Chemistry 2007 282 11 7753 7757 2-s2.0-34247183643 10.1074/jbc.C600318200
41. Calder P. C., Yaqoob P., Harvey D. J., Watts A., Newsholme E. A., Incorporation of fatty acids by concanavalin A-stimulated lymphocytes and the effect on fatty acid composition and membrane fluidity. Biochemical Journal 1994 300 2 509 518 2-s2.0-0028200972
42. Blüher M., Engeli S., Klöting N., Berndt J., Fasshauer M., Bátkai S., Pacher P., Schön M. R., Jordan J., Stumvoll M., Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes 2006 55 11 3053 3060 2-s2.0-33845522074 10.2337/db06-0812
43. Côté M., Matias I., Lemieux I., Petrosino S., Alméras N., Després J. P., Di Marzo V., Circulating endocannabinoid levels, abdominal adiposity and related cardiometabolic risk factors in obese men. International Journal of Obesity 2007 31 4 692 699 2-s2.0-33947606528 10.1038/sj.ijo.0803539
44. Thomas B., Bishop J., Manual of Dietetic Practice 2007 4th Oxford, UK Blackwell Publishing
45. Cable J. C., Tan G. D., Alexander S. P. H., O'Sullivan S. E., The activity of the endocannabinoid metabolising enzyme fatty acid amide hydrolase in subcutaneous adipocytes correlates with BMI in metabolically healthy humans. Lipids in Health and Disease 2011 10 1 129 138 2-s2.0-79961107777 10.1186/1476-511X-10-129
46. Zhang Y., Sonnenberg G. E., Baye T. M., Littrell J., Gunnell J., DeLaForest A., MacKinney E., Hillard C. J., Kissebah A. H., Olivier M., Wilke R. A., Obesity-related dyslipidemia associated with FAAH, independent of insulin response, in multigenerational families of Northern European descent. Pharmacogenomics 2009 10 12 1929 1939 2-s2.0-73649131984 10.2217/pgs.09.122
47. Murdolo G., Kempf K., Hammarstedt A., Herder C., Smith U., Jansson P. A., Insulin differentially modulates the peripheral endocannabinoid system in human subcutaneous abdominal adipose tissue from lean and obese individuals. Journal of Endocrinological Investigation 2007 30 8 RC17 RC21 2-s2.0-35449002089
48. D'Eon T. M., Pierce K. A., Roix J. J., Tyler A., Chen H., Teixeira S. R., The role of adipocyte insulin resistance in the pathogenesis of obesity-related elevations in endocannabinoids. Diabetes 2008 57 5 1262 1268 2-s2.0-48149109160 10.2337/db07-1186
49. Massa F., Mancini G., Schmidt H., Steindel F., Mackie K., Angioni C., Oliet S. H. R., Geisslinger G., Lutz B., Alterations in the hippocampal endocannabinoid system in diet-induced obese mice. The Journal of Neuroscience 2010 30 18 6273 6281 2-s2.0-77951777420 10.1523/JNEUROSCI.2648-09.2010
50. Pagano C., Pilon C., Calcagno A., Urbanet R., Rossato M., Milan G., Bianchi K., Rizzuto R., Bernante P., Federspil G., Vettor R., The endogenous cannabinoid system stimulates glucose uptake in human fat cells via phosphatidylinositol 3-kinase and calcium-dependent mechanisms. The Journal of Clinical Endocrinology and Metabolism 2007 92 12 4810 4819 2-s2.0-35348961244 10.1210/jc.2007-0768
51. Karvela A., Paola Rojas-Gi A., Samkinidou E., Papadaki H., Pappa A., Georgiou G., Spiliotis B. E., Endocannabinoid (EC) receptor, CB1, and EC enzymes' expression in primary adipocyte cultures of Lean and Obese Pre-pubertal Children in Relation to Adiponectin and Insulin. Journal of Pediatric Endocrinology and Metabolism 2010 23 10 1011 1024 2-s2.0-79951470005 10.1515/jpem.2010.162
52. Rivera P., Luque-Rojas M. J., Pastor A., Blanco E., Pavón F. J., Serrano A., Crespillo A., Vida M., Grondona J. M., Cifuentes M., Bermúdez-Silva F. J., de la Torre R., de Fonseca F. R., Suárez J., Diet-dependent modulation of hippocampal expression of endocannabinoid signaling-related proteins in cannabinoid antagonist-treated obese rats. European Journal of Neuroscience 2013 37 1 105 117 10.1111/ejn.12012
53. Bennetzen M. F., Wellner N., Ahmed S. S., Ahmed S. M., Diep T. A., Hansen H. S., Richelsen B., Pedersen S. B., Investigations of the human endocannabinoid system in two subcutaneous adipose tissue depots in lean subjects and in obese subjects before and after weight loss. International Journal of Obesity 2011 35 11 1377 1384 10.1038/ijo.2011.8
54. Sarzani R., Bordicchia M., Marcucci P., Bedetta S., Santini S., Giovagnoli A., Scappini L., Minardi D., Muzzonigro G., Dessì-Fulgheri P., Rappelli A., Altered pattern of cannabinoid type 1 receptor expression in adipose tissue of dysmetabolic and overweight patients. Metabolism 2009 58 3 361 367 2-s2.0-59649102201 10.1016/j.metabol.2008.10.009
55. You T., Disanzo B. L., Wang X., Yang R., Gong D., Adipose tissue endocannabinoid system gene expression: depot differences and effects of diet and exercise. Lipids in Health and Disease 2011 10 article 194 10.1186/1476-511X-10-194
56. Izzo A. A., Piscitelli F., Capasso R., Aviello G., Romano B., Borrelli F., Petrosino S., Di Marzo V., Peripheral endocannabinoid dysregulation in obesity: relation to intestinal motility and energy processing induced by food deprivation and re-feeding. British Journal of Pharmacology 2009 158 2 451 461 2-s2.0-68349129115 10.1111/j.1476-5381.2009.00183.x
57. Di Marzo V., Verrijken A., Hakkarainen A., Petrosino S., Mertens I., Lundbom N., Piscitelli F., Westerbacka J., Soro-Paavonen A., Matias I., Van Gaal L., Taskinen M. R., Role of insulin as a negative regulator of plasma endocannabinoid levels in obese and nonobese subjects. European Journal of Endocrinology 2009 161 5 715 722 2-s2.0-70449726605 10.1530/EJE-09-0643
58. Motaghedi R., McGraw T. E., The CB1 endocannabinoid system modulates adipocyte insulin sensitivity. Obesity 2008 16 8 1727 1734 2-s2.0-48749100198 10.1038/oby.2008.309
59. Gasperi V., Fezza F., Pasquariello N., Bari M., Oddi S., Finazzi Agrò A., Maccarrone M., Endocannabinoids in adipocytes during differentiation and their role in glucose uptake. Cellular and Molecular Life Sciences 2007 64 2 219 229 2-s2.0-33846492418 10.1007/s00018-006-6445-4
60. Tontonoz P., Hu E., Spiegelman B. M., Stimulation of adipogenesis in fibroblasts by PPAR γ 2, a lipid-activated transcription factor. Cell 1994 79 7 1147 1156 2-s2.0-0028641559
61. Matias I., Gonthier M. P., Orlando P., Martiadis V., de Petrocellis L., Cervino C., Petrosino S., Hoareau L., Festy F., Pasquali R., Roche R., Maj M., Pagotto U., Monteleone P., Di Marzo V., Regulation, function, and dysregulation of endocannabinoids in models of adipose and β -pancreatic cells and in obesity and hyperglycemia. The Journal of Clinical Endocrinology and Metabolism 2006 91 8 3171 3180 2-s2.0-33747644061 10.1210/jc.2005-2679
62. Perwitz N., Fasshauer M., Klein J., Cannabinoid receptor signaling directly inhibits thermogenesis and alters expression of adiponectin and visfatin. Hormone and Metabolic Research 2006 38 5 356 358 2-s2.0-33744986319 10.1055/s-2006-925401
63. Song D., Bandsma R. H. J., Xiao C., Xi L., Shao W., Jin T., Lewis G. F., Acute cannabinoid receptor type 1 (CB1R) modulation influences insulin sensitivity by an effect outside the central nervous system in mice. Diabetologia 2011 54 5 1181 1189 2-s2.0-79954629673 10.1007/s00125-011-2082-z
64. Lindborg K. A., Teachey M. K., Jacob S., Henriksen E. J., Effects of in vitro antagonism of endocannabinoid-1 receptors on the glucose transport system in normal and insulin-resistant rat skeletal muscle. Diabetes, Obesity and Metabolism 2010 12 8 722 730 2-s2.0-77958105428 10.1111/j.1463-1326.2010.01227.x
65. Gatta-Cherifi B., Matias I., Vallée M., Tabarin A., Marsicano G., Piazza P. V., Cota D., Simultaneous postprandial deregulation of the orexigenic endocannabinoid anandamide and the anorexigenic peptide YY in obesity. International Journal of Obesity 2011 36 6 880 885
66. Matias I., Gatta-Cherifi B., Tabarin A., Clark S., Leste-Lasserre T., Marsicano G., Piazza P. V., Cota D., Endocannabinoids measurement in human saliva as potential biomarker of obesity. PLoS ONE 2012 7 7, article e42399
67. Higuchi S., Irie K., Yamaguchi R., Katsuki M., Araki M., Ohji M., Hayakawa K., Mishima S., Akitake Y., Matsuyama K., Mishima K., Iwasaki K., Fujiwara M., Hypothalamic 2-arachidonoylglycerol regulates multistage process of high-fat diet preferences. PLoS ONE 2012 7 6, article e38609
68. Joosten M. M., Balvers M. G. J., Verhoeckx K. C. M., Hendriks H. F. J., Witkamp R. F., Plasma anandamide and other N-acylethanolamines are correlated with their corresponding free fatty acid levels under both fasting and non-fasting conditions in women. Nutrition & Metabolism 2010 7, article 49 2-s2.0-77953349489 10.1186/1743-7075-7-49
69. Drewnowski A., Popkin B. M., The nutrition transition: new trends in the global diet. Nutrition Reviews 1997 55 2 31 43 2-s2.0-0030940257
70. Drewnowski A., Schrager E. E., Lipsky C., Stellar E., Greenwood M. R. C., Sugar and fat: sensory and hedonic evaluation of liquid and solid foods. Physiology and Behavior 1989 45 1 177 183 2-s2.0-0024602486
71. Di Marzo V., Capasso R., Matias I., Aviello G., Petrosino S., Borrelli F., Romano B., Orlando P., Capasso F., Izzo A. A., The role of endocannabinoids in the regulation of gastric emptying: alterations in mice fed a high-fat diet. British Journal of Pharmacology 2008 153 6 1272 1280 2-s2.0-40949147440 10.1038/sj.bjp.0707682
72. Diep T. A., Madsen A. N., Holst B., Kristiansen M. M., Wellner N., Hansen S. H., Hansen H. S., Dietary fat decreases intestinal levels of the anorectic lipids through a fat sensor. The FASEB Journal 2011 25 2 765 774 2-s2.0-79551626653 10.1096/fj.10-166595
73. DiPatrizio N. V., Astarita G., Schwartz G., Li X., Piomelli D., Endocannabinoid signal in the gut controls dietary fat intake. Proceedings of the National Academy of Sciences of the United States of America 2011 108 31 12904 12908 10.1073/pnas.1104675108
74. Piscitelli F., Carta G., Bisogno T., Murru E., Cordeddu L., Berge K., Tandy S., Cohn J. S., Griinari M., Banni S., Di Marzo V., Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high fat-fed mice. Nutrition & Metabolism 2011 8 1, article 51 2-s2.0-79960167580 10.1186/1743-7075-8-51
75. Osei-Hyiaman D., DePetrillo M., Pacher P., Liu J., Radaeva S., Bátkai S., Harvey-White J., Mackie K., Offertáler L., Wang L., Kunos G., Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. Journal of Clinical Investigation 2005 115 5 1298 1305 2-s2.0-20944436157 10.1172/JCI200523057
76. Aviello G., Matias I., Capasso R., Petrosino S., Borrelli F., Orlando P., Romano B., Capasso F., Di Marzo V., Izzo A. A., Inhibitory effect of the anorexic compound oleoyl ethanolamide on gastric emptying in control and overweight mice. Journal of Molecular Medicine 2008 86 4 413 422 2-s2.0-42449117932 10.1007/s00109-008-0305-7
77. Dipatrizio N. V., Joslin A., Jung K. M., Piomelli D., Endocannabinoid signaling in the gut mediates preference for dietary unsaturated fats. The FASEB Journal 2013 10.1096/fj.13-227587
78. Terrazzino S., Berto F., Carbonare M. D., Fabris M., Guiotto A., Bernardini D., Leon A., Stearoylethanolamide exerts anorexic effects in mice via down-regulation of liver stearoyl-coenzyme A desaturase-1 mRNA expression. The FASEB Journal 2004 18 13 1580 1582 2-s2.0-9444271640 10.1096/fj.03-1080fje
79. Fu J., Astarita G., Gaetani S., Kim J., Cravatt B. F., Mackie K., Piomelli D., Food intake regulates oleoyl ethanolamide formation and degradation in the proximal small intestine. Journal of Biological Chemistry 2007 282 2 1518 1528 2-s2.0-33847734027 10.1074/jbc.M607809200
80. Artmann A., Petersen G., Hellgren L. I., Boberg J., Skonberg C., Nellemann C., Hansen S. H., Hansen H. S., Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. Biochimica et Biophysica Acta-Molecular and Cell Biology of Lipids 2008 1781 4 200 212 2-s2.0-40949151048 10.1016/j.bbalip.2008.01.006
81. Rodríguez de Fonseca F., Navarro M., Gómez R., Escuredo L., Nava F., Fu J., Murillo-Rodríguez E., Giuffrida A., Loverme J., Gaetani S., Kathuria S., Gall C., Piomelli D., An anorexic lipid mediator regulated by feeding. Nature 2001 414 6860 209 212 2-s2.0-0035829625 10.1038/35102582
82. LoVerme J., Russo R., La Rana G., Fu J., Farthing J., Mattace-Raso G., Meli R., Hohmann A., Calignano A., Piomelli D., Rapid broad-spectrum analgesia through activation of peroxisome proliferator-activated receptor- α Journal of Pharmacology and Experimental Therapeutics 2006 319 3 1051 1061 2-s2.0-33751166817 10.1124/jpet.106.111385
83. Ryberg E., Larsson N., Sjögren S., Hjorth S., Hermansson N. O., Leonova J., Elebring T., Nilsson K., Drmota T., Greasley P. J., The orphan receptor GPR55 is a novel cannabinoid receptor. British Journal of Pharmacology 2007 152 7 1092 1101 2-s2.0-35649015179 10.1038/sj.bjp.0707460
84. Jonsson K. O., Vandevoorde S., Lambert D. M., Tiger G., Fowler C. J., Effects of homologues and analogues of palmitoyl ethanolamide upon the inactivation of the endocannabinoid anandamide. British Journal of Pharmacology 2001 133 8 1263 1275 2-s2.0-0034864463
85. Feltrin K. L., Little T. J., Meyer J. H., Horowitz M., Smout A. J. P. M., Wishart J., Pilichiewicz A. N., Rades T., Chapman I. M., Feinle-Bisset C., Effects of intraduodenal fatty acids on appetite, antropyloroduodenal motility, and plasma CCK and GLP-1 in humans vary with their chain length. American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2004 287 3 R524 R533 2-s2.0-4143060169 10.1152/ajpregu.00039.2004
86. Little T. J., Feltrin K. L., Horowitz M., Smout A. J. P. M., Rades T., Meyer J. H., Pilichiewicz A. N., Wishart J., Feinle-Bisset C., Dose-related effects of lauric acid on antropyloroduodenal motility, gastrointestinal hormone release, appetite, and energy intake in healthy men. American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2005 289 4 R1090 R1098 2-s2.0-25844521136 10.1152/ajpregu.00290.2005
87. Feltrin K. L., Little T. J., Meyer J. H., Horowitz M., Rades T., Wishart J., Feinle-Bisset C., Comparative effects of intraduodenal infusions of lauric and oleic acids on antropyloroduodenal motility, plasma cholecystokinin and peptide YY, appetite, and energy intake in healthy men. American Journal of Clinical Nutrition 2008 87 5 1181 1187 2-s2.0-43549124815
88. Schwartz G. J., Fu J., Astarita G., Li X., Gaetani S., Campolongo P., Cuomo V., Piomelli D., The lipid messenger OEA links dietary fat intake to satiety. Cell Metabolism 2008 8 4 281 288 2-s2.0-52749087007 10.1016/j.cmet.2008.08.005
89. Serrano A., Pavón F. J., Tovar S., Casanueva F., Señarís R., Diéguez C., de Fonseca F. R., Oleoyl ethanolamide: effects on hypothalamic transmitters and gut peptides regulating food intake. Neuropharmacology 2011 60 4 593 601
90. Nielsen M. J., Petersen G., Astrup A., Hansen H. S., Food intake is inhibited by oral oleoyl ethanolamide. Journal of Lipid Research 2004 45 6 1027 1029 2-s2.0-2542429161 10.1194/jlr.C300008-JLR200
91. Soria-Gómez E., Guzmán K., Pech-Rueda O., Montes-Rodríguez C. J., Cisneros M., Prospéro-García O., Oleoyl ethanolamide affects food intake and sleep-waking cycle through a hypothalamic modulation. Pharmacological Research 2010 61 5 379 384 10.1016/j.phrs.2010.01.010
92. Gaetani S., Oveisi F., Piomelli D., Modulation of meal pattern in the rat by the anorexic lipid mediator oleoyl ethanolamide. Neuropsychopharmacology 2003 28 7 1311 1316 2-s2.0-0042924150 10.1038/sj.npp.1300166
93. Thabuis C., Destaillats F., Landrier J. F., Tissot-Favre D., Martin J. C., Analysis of gene expression pattern reveals potential targets of dietary oleoyl ethanolamide in reducing body fat gain in C3H mice. Journal of Nutritional Biochemistry 2010 21 10 922 928 2-s2.0-77956648769 10.1016/j.jnutbio.2009.07.006
94. Fu J., Oveisi F., Gaetani S., Lin E., Piomelli D., Oleoyl ethanolamide, an endogenous PPAR- α agonist, lowers body weight and hyperlipidemia in obese rats. Neuropharmacology 2005 48 8 1147 1153 2-s2.0-19444372260 10.1016/j.neuropharm.2005.02.013
95. Cluny N. L., Keenan C. M., Lutz B., Piomelli D., Sharkey K. A., The identification of peroxisome proliferator-activated receptor alpha-independent effects of oleoyl ethanolamide on intestinal transit in mice. Neurogastroenterology and Motility 2009 21 4 420 429 2-s2.0-62449123202 10.1111/j.1365-2982.2008.01248.x
96. Fu J., Gaetani S., Oveisi F., Lo Verme J., Serrano A., de Fonseca F. R., Rosengarth A., Luecke H., Di Giacomo B., Tarzia G., Piomelli D., Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR- α Nature 2003 425 6953 90 93 2-s2.0-0041321275 10.1038/nature01921
97. Motojima K., Passilly P., Peters J. M., Gonzalez F. J., Latruffe N., Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor α and γ activators in a tissue- and inducer-specific manner. Journal of Biological Chemistry 1998 273 27 16710 16714 2-s2.0-0032479423 10.1074/jbc.273.27.16710
98. Dreyer C., Krey G., Keller H., Givel F., Helftenbein G., Wahli W., Control of the peroxisomal β -oxidation pathway by a novel family of nuclear hormone receptors. Cell 1992 68 5 879 887 2-s2.0-0026517010 10.1016/0092-8674(92)90031-7
99. Schoonjans K., Watanabe M., Suzuki H., Mahfoudi A., Krey G., Wahli W., Grimaldi P., Staels B., Yamamoto T., Auwerx J., Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter. Journal of Biological Chemistry 1995 270 33 19269 19276 2-s2.0-0029144018 10.1074/jbc.270.33.19269
100. Oh Y. T., Lee J. Y., Lee J., Lee J. H., Kim J. E., Ha J., Kang I., Oleamide suppresses lipopolysaccharide-induced expression of iNOS and COX-2 through inhibition of NF- B activation in BV2 murine microglial cells. Neuroscience Letters 2010 474 3 148 153 2-s2.0-77951499518 10.1016/j.neulet. 2010.03.026
101. Oh Y. T., Lee J. Y., Lee J., Kim H., Yoon K. S., Choe W., Kang I., Oleic acid reduces lipopolysaccharide-induced expression of iNOS and COX-2 in BV2 murine microglial cells: possible involvement of reactive oxygen species, p38 MAPK, and IKK/NF- B signaling pathways. Neuroscience Letters 2009 464 2 93 97 2-s2.0-69549085106 10.1016/j.neulet.2009.08.040
102. Guzmán M., Lo Verme J., Fu J., Oveisi F., Blázquez C., Piomelli D., Oleoyl ethanolamide stimulates lipolysis by activating the nuclear receptor peroxisome proliferator-activated receptor α (PPAR- α). Journal of Biological Chemistry 2004 279 27 27849 27854 2-s2.0-3142583174 10.1074/jbc.M404087200
103. Yang Y., Chen M., Georgeson K. E., Harmon C. M., Mechanism of oleoyl ethanolamide on fatty acid uptake in small intestine after food intake and body weight reduction. American Journal of Physiology-Regulatory Integrative and Comparative Physiology 2007 292 1 R235 R241 2-s2.0-33846177900 10.1152/ajpregu.00270.2006
104. González-Yanes C., Serrano A., Bermúdez-Silva F. J., Hernández-Dominguez M., Páez-Ochoa M. A., Rodríguez de Fonseca F., Sánchez-Margalet V., Oleylethanolamide impairs glucose tolerance and inhibits insulin-stimulated glucose uptake in rat adipocytes through p38 and JNK MAPK pathways. American Journal of Physiology-Endocrinology and Metabolism 2005 289 5 E923 E929 2-s2.0-27144462551 10.1152/ajpendo.00555. 2004
105. Gómez R., Navarro M., Ferrer B., Trigo J. M., Bilbao A., Arco I. D., Cippitelli A., Nava F., Piomelli D., De Fonseca F. R., A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding. The Journal of Neuroscience 2002 22 21 9612 9617 2-s2.0-0036849961
106. Garaulet M., Pérez-Llamas F., Pérez-Ayala M., Martínez P., Sánchez De Medina F., Tebar F. J., Zamora S., Site-specific differences in the fatty acid composition of abdominal adipose tissue in an obese population from a mediterranean area: relation with dietary fatty acids, plasma lipid profile, serum insulin, and central obesity. American Journal of Clinical Nutrition 2001 74 5 585 591 2-s2.0-0034751831
107. Hutchins H. L., Li Y., Hannon K., Watkins B. A., Eicosapentaenoic acid decreases expression of anandamide synthesis enzyme and cannabinoid receptor 2 in osteoblast-like cells. Journal of Nutritional Biochemistry 2011 22 2 195 200 2-s2.0-78651231132 10.1016/j.jnutbio.2010.06.001
108. Song J. H., Fujimoto K., Miyazawa T., Polyunsaturated (n-3) fatty acids susceptible to peroxidation are increased in plasma and tissue lipids of rats fed docosahexaenoic acid-containing oils. The Journal of Nutrition 2000 130 12 3028 3033 2-s2.0-0034536758
109. Wood J. T., Williams J. S., Pandarinathan L., Janero D. R., Lammi-Keefe C. J., Makriyannis A., Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma. Journal of Lipid Research 2010 51 6 1416 1423 2-s2.0-77952738210 10.1194/jlr.M002436
110. Balvers M. G. J., Verhoeckx K. C. M., Plastina P., Wortelboer H. M., Meijerink J., Witkamp R. F., Docosahexaenoic acid and eicosapentaenoic acid are converted by 3T3-L1 adipocytes to N-acyl ethanolamines with anti-inflammatory properties. Biochimica et Biophysica Acta-Molecular and Cell Biology of Lipids 2010 1801 10 1107 1114 2-s2.0-77955508948 10.1016/j.bbalip.2010.06.006
111. Matias I., Carta G., Murru E., Petrosino S., Banni S., Di Marzo V., Effect of polyunsaturated fatty acids on endocannabinoid and N-acyl-ethanolamine levels in mouse adipocytes. Biochimica et Biophysica Acta-Molecular and Cell Biology of Lipids 2008 1781 1-2 52 60 2-s2.0-39049106999 10.1016/j.bbalip.2007. 11.001
112. Banni S., Carta G., Murru E., Cordeddu L., Giordano E., Sirigu A. R., Berge K., Vik H., Maki K. C., Di Marzo V., Griinari M., Krill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese subjects. Nutrition & Metabolism 2011 8, article 7 2-s2.0-79251564054 10.1186/1743-7075-8-7
113. Batetta B., Griinari M., Carta G., Murru E., Ligresti A., Cordeddu L., Giordano E., Sanna F., Bisogno T., Uda S., Collu M., Bruheim I., Di Marzo V., Banni S., Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats. The Journal of Nutrition 2009 139 8 1495 1501 2-s2.0-67749139564 10.3945/jn.109.104844
114. Balvers M. G., Verhoeckx K. C., Bijlsma S., Rubingh C. M., Meijerink J., Wortelboer H. M., Witkamp R. F., Fish oil and inflammatory status alter the n-3 to n-6 balance of the endocannabinoid and oxylipin metabolomes in mouse plasma and tissues. Metabolomics 2012 8 6 1130 1147 10.1007/s11306-012-0421-9
115. Di Marzo V., Griinari M., Carta G., Murru E., Ligresti A., Cordeddu L., Giordano E., Bisogno T., Collu M., Batetta B., Uda S., Berge K., Banni S., Dietary krill oil increases docosahexaenoic acid and reduces 2-arachidonoylglycerol but not N-acylethanolamine levels in the brain of obese Zucker rats. International Dairy Journal 2010 20 4 231 235 2-s2.0-75549090956 10.1016/j.idairyj.2009.11.015
116. Thorsdottir I., Tomasson H., Gunnarsdottir I., Gisladottir E., Kiely M., Parra M. D., Bandarra N. M., Schaafsma G., Martinéz J. A., Randomized trial of weight-loss-diets for young adults varying in fish and fish oil content. International Journal of Obesity 2007 31 10 1560 1566 2-s2.0-34748898916 10.1038/sj.ijo.0803643
117. Ruzickova J., Rossmeisl M., Prazak T., Flachs P., Sponarova J., Vecka M., Tvrzicka E., Bryhn M., Kopecky J., Omega-3 PUFA of marine origin limit diet-induced obesity in mice by reducing cellularity of adipose tissue. Lipids 2004 39 12 1177 1185 2-s2.0-12544260664 10.1007/s11745-004-1345-9
118. Rossmeisl M., Jilkova Z. M., Kuda O., Jelenik T., Medrikova D., Stankova B., Kristinsson B., Haraldsson G. G., Svensen H., Stoknes I., Metabolic effects of N-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: possible role of endocannabinoids. PLoS ONE 2012 7 6, article e38834
119. Frøyland L., Madsen L., Vaagenes H., Totland G. K., Auwerx J., Kryvi H., Staels B., Berge R. K., Mitochondrion is the principal target for nutritional and pharmacological control of triglyceride metabolism. Journal of Lipid Research 1997 38 9 1851 1858 2-s2.0-0030764696
120. Yoshikawa T., Shimano H., Yahagi N., Ide T., Amemiya-Kudo M., Matsuzaka T., Nakakuki M., Tomita S., Okazaki H., Tamura Y., Iizuka Y., Ohashi K., Takahashi A., Sone H., Osuga J. I., Gotoda T., Ishibashi S., Yamada N., Polyunsaturated fatty acids suppress sterol regulatory element-binding protein 1c promoter activity by inhibition of liver X receptor (LXR) binding to LXR response elements. Journal of Biological Chemistry 2002 277 3 1705 1711 2-s2.0-18544388579 10.1074/jbc.M105711200
121. Simopoulos A. P., Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomedicine and Pharmacotherapy 2006 60 9 502 507 2-s2.0-33750284280 10.1016/j.biopha.2006.07.080
122. Kris-Etherton P. M., Taylor D. S., Yu-Poth S., Huth P., Moriarty K., Fishell V., Hargrove R. L., Zhao G., Etherton T. D., Polyunsaturated fatty acids in the food chain in the United States. American Journal of Clinical Nutrition 2000 71 supplement 1 179S 188S 2-s2.0-0033954765
123. Massiera F., Barbry P., Guesnet P., Joly A., Luquet S., Moreilhon-Brest C., Mohsen-Kanson T., Amri E. Z., Ailhaud G., A Western-like fat diet is sufficient to induce a gradual enhancement in fat mass over generations. Journal of Lipid Research 2010 51 8 2352 2361 2-s2.0-77956866205 10.1194/jlr.M006866
124. Massiera F., Saint-Marc P., Seydoux J., Murata T., Kobayashi T., Narumiya S., Guesnet P., Amri E. Z., Negrel R., Ailhaud G., Arachidonic acid and prostacyclin signaling promote adipose tissue development: a human health concern? Journal of Lipid Research 2003 44 2 271 279 2-s2.0-10744233743 10.1194/jlr.M200346-JLR200
125. Madigan C., Ryan M., Owens D., Collins P., Tomkin G. H., Dietary unsaturated fatty acids in type 2 diabetes: higher levels of postprandial lipoprotein on a linoleic acid-rich sunflower oil diet compared with an oleic acid-rich olive oil diet. Diabetes Care 2000 23 10 1472 1477 2-s2.0-0033803424
126. Simopoulos A. P., Is insulin resistance influenced by dietary linoleic acid and trans fatty acids? Free Radical Biology and Medicine 1994 17 4 367 372 2-s2.0-0027932647 10.1016/0891-5849(94)90023-X
127. Alvheim A. R., Torstensen B. E., Lin Y. H., Lillefosse H. H., Lock E. J., Madsen L., Hibbeln J. R., Malde M. K., Dietary linoleic acid elevates endogenous 2-arachidonoylglycerol and anandamide in Atlantic salmon (Salmo salar L.) and mice, and induces weight gain and inflammation in mice. The British Journal of Nutrition 2012 109 8 1508 1517
128. Matias I., Petrosino S., Racioppi A., Capasso R., Izzo A. A., Di Marzo V., Dysregulation of peripheral endocannabinoid levels in hyperglycemia and obesity: effect of high fat diets. Molecular and Cellular Endocrinology 2008 286 1-2 supplement 1 S66 S78 2-s2.0-42249099620 10.1016/j.mce.2008.01.026